Evidence map›Paper›PMID 16510851›Full record

ArticleNucleic acids research2006

A reliable method to display authentic DNase I hypersensitive sites at long-ranges in single-copy genes from large genomes.

Matthew E Pipkin, Mathias G Lichtenheld

Abstract readEvaluation Study
In one paragraph

Article in Nucleic acids research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Early programming of CD8Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matthew E PipkinDepartment of Microbiology and Immunology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
Mathias G Lichtenheld

Funding

MOLECULAR CHARACTERIZATION OF PERFORIN GENE REGULATIONR01CA055811 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LICHTENHELD, MATHIAS GEORG · 1998 to 2001
$433k
6 · The paper itself

Abstract

The study of eukaryotic gene transcription depends on methods to discover distal cis-acting control sequences. Comparative bioinformatics is one powerful strategy to reveal these domains, but still requires conventional wet-bench techniques to elucidate their specificity and function. The DNase I hypersensitivity assay (DHA) is also a method to identify regulatory domains, but can also suggest their function. Technically however, the classical DHA is constrained to mapping gene loci in small increments of approximately 20 kb. This limitation hinders efficient and comprehensive analysis of distal gene regions. Here, we report an improved method termed mega-DHA that extends the range of existing DHAs to facilitate assaying intervals that approach 100 kb. We demonstrate its feasibility for efficient analysis of single-copy genes within a large and complex genome by assaying 230 kb of the human ADAMTS14-perforin-paladin gene cluster in four experiments. The results identify distinct networks of regulatory domains specific to expression of perforin and its two neighboring genes.

Indexed as

Deoxyribonuclease IRegulatory Elements, TranscriptionalAnimalsCell LineChromosome MappingChromosomes, Human, Pair 10Electrophoresis, Gel, Pulsed-FieldGene DosageGenome, HumanGenomicsHumansMembrane GlycoproteinsMicePerforinPore Forming Cytotoxic ProteinsTranscription, GeneticDeoxyribonuclease IMembrane GlycoproteinsPerforinPore Forming Cytotoxic Proteins

Identifiers

PMID16510851
PMCPMC1388096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.